Aldeyra Therapeutics, Inc(NASDAQ:ALDX) 
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and alle...
Website: http://www.aldeyra.com
Founded: 2004
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.40
H 2.00
L 1.38
C 1.89
V 13,065,474
10EMA 1.89
20EMA 1.89
60EMA 1.89
120EMA 1.89
250EMA 1.89